Patents by Inventor Chris Polman

Chris Polman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genotyping tool for improving the prognostic and clinical management of MS patients
    Patent number: 8835111
    Abstract: The invention relates to methods of evaluating MS severity based on analysis of single nucleotide polymorphisms (SNPs) and to products and kits for use in such methods.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: September 16, 2014
    Assignee: Brainco Biopharma S.L.
    Inventors: David Arteta, Marta Artieda, Diego Tejedor, Antonio Martinez, Laureano Simon, Bart A. Crusius, Salvador Pena, Madeleine Sombekke, Bernard Uitdehaag, Chris Polman
  • GENOTYPING TOOL FOR IMPROVING THE PROGNOSTIC AND CLINICAL MANAGEMENT OF MS PATIENTS
    Publication number: 20120065096
    Abstract: The invention relates to methods of evaluating MS severity based on analysis of single nucleotide polymorphisms (SNPs) and to products and kits for use in such methods.
    Type: Application
    Filed: March 12, 2010
    Publication date: March 15, 2012
    Inventors: David Arteta, Marta Artieda, Diego Tejedor, Antonio Martinez, Laureano Simon, Bart A. Crusius, Salvador Pena, Madeleine Sombekke, Bernard Uitdehaag, Chris Polman
  • USE OF RILUZOLE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20080214631
    Abstract: Methods and compositions for the treatment of multiple sclerosis comprising riluzole (6-(trifluoromethoxy)-benzothiazolamine) are disclosed herein.
    Type: Application
    Filed: January 24, 2008
    Publication date: September 4, 2008
    Inventor: Chris Polman
  • Use of riluzole for the treatment of multiple sclerosis
    Patent number: 7342033
    Abstract: Methods and compositions for the treatment of multiple sclerosis comprising riluzole (6-(trifluoromethoxy)-benzothiazolamine) are disclosed herein.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: March 11, 2008
    Assignee: Vereniging Voor Christelijk Wetenschappelijk Onderwijs
    Inventor: Chris Polman
  • Use of riluzole for the treatment of multiple sclerosis
    Publication number: 20050171168
    Abstract: Methods and compositions for the treatment of multiple sclerosis comprising riluzole (6-(trifluoromethoxy)-benzothiazolamine) are disclosed herein.
    Type: Application
    Filed: March 25, 2005
    Publication date: August 4, 2005
    Inventor: Chris Polman
  • Use of riluzole for the treatment of multiple sclerosis
    Patent number: 6872739
    Abstract: Methods for the treatment of multiple sclerosis are disclosed comprising administering 6-(triflouromethoxy)-2-benzothiazolamine or a salt thereof.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: March 29, 2005
    Assignee: Vereniging Voor Christelijk Wetenshappelikjk Onderwijs
    Inventor: Chris Polman